Mitochondrial fission proteins regulate programmed cell death in yeast

  1. Yihru Fannjiang1,8,
  2. Wen-Chih Cheng2,8,
  3. Sarah J. Lee3,
  4. Bing Qi2,
  5. Jonathan Pevsner3,4,
  6. J. Michael McCaffery5,6,
  7. R. Blake Hill5,
  8. Gorka Basañez7, and
  9. J. Marie Hardwick1,2,3,4,9
  1. 1Department of Pharmacology and Molecular Sciences, 2Department of Molecular Microbiology and Immunology, 3Department of Neuroscience, 4Department of Neurology, 5Department of Biology, and 6Integrated Imaging Center, Johns Hopkins University Schools of Medicine and Public Health, and the Kennedy Krieger Institute, Baltimore, Maryland 21205, USA; 7Unidad de Biofisica, Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Bilbao 48080, Spain

Abstract

The possibility that single-cell organisms undergo programmed cell death has been questioned in part because they lack several key components of the mammalian cell death machinery. However, yeast encode a homolog of human Drp1, a mitochondrial fission protein that was shown previously to promote mammalian cell death and the excessive mitochondrial fragmentation characteristic of apoptotic mammalian cells. In support of a primordial origin of programmed cell death involving mitochondria, we found that the Saccharomyces cerevisiae homolog of human Drp1, Dnm1, promotes mitochondrial fragmentation/degradation and cell death following treatment with several death stimuli. Two Dnm1-interacting factors also regulate yeast cell death. The WD40 repeat protein Mdv1/Net2 promotes cell death, consistent with its role in mitochondrial fission. In contrast to its fission function in healthy cells, Fis1 unexpectedly inhibits Dnm1-mediated mitochondrial fission and cysteine protease-dependent cell death in yeast. Furthermore, the ability of yeast Fis1 to inhibit mitochondrial fission and cell death can be functionally replaced by human Bcl-2 and Bcl-xL. Together, these findings indicate that yeast and mammalian cells have a conserved programmed death pathway regulated by a common molecular component, Drp1/Dnm1, that is inhibited by a Bcl-2-like function.

Keywords

Footnotes

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1247904.

  • 8 These authors contributed equally to this work.

  • 9 Corresponding author. E-MAIL hardwick{at}jhu.edu; FAX (410) 955-0105.

    • Accepted September 15, 2004.
    • Received August 9, 2004.
| Table of Contents

Life Science Alliance